...
首页> 外文期刊>The Journal of pediatrics >Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial
【24h】

Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial

机译:一种新型微生物脂肪酶在囊性纤维化引起的胰腺功能不全的患者中的安全性和疗效:随机对照临床试验

获取原文
获取原文并翻译 | 示例

摘要

Objective To evaluate the safety and efficacy of a novel microbial lipase (NM-BL) in a liquid formulation for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) in a phase IIa proof-of-concept study.
机译:目的探讨一种新型微生物脂肪酶(NM-BL)在液体纤维化(CF)患者患者中患者液体制剂中的一种新型微生物脂肪酶(NM-BL)的安全性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号